Sergio Parra

1.2k total citations
35 papers, 609 citations indexed

About

Sergio Parra is a scholar working on Molecular Biology, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sergio Parra has authored 35 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Physiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sergio Parra's work include Receptor Mechanisms and Signaling (9 papers), Asthma and respiratory diseases (7 papers) and Neuropeptides and Animal Physiology (5 papers). Sergio Parra is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Asthma and respiratory diseases (7 papers) and Neuropeptides and Animal Physiology (5 papers). Sergio Parra collaborates with scholars based in United States, Colombia and United Kingdom. Sergio Parra's co-authors include Richard A. Bond, Brian J. Knoll, Long Nguyễn, Burton F. Dickey, Ozozoma Omoluabi, Michael J. Tuvim, Rui Lin, Nicola A. Hanania, Felix R. Shardonofsky and Clive Page and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and European Heart Journal.

In The Last Decade

Sergio Parra

28 papers receiving 597 citations

Peers

Sergio Parra
P. Devillier France
F Perretti Italy
Annet B. Zuidhof Netherlands
K H Muntz United States
T J Torphy United States
Kihachi Ohshima Japan
Adrian N. Payne United Kingdom
Blanca Bazán‐Perkins Mexico
Carl P. Nelson United Kingdom
Marilyn Grous United States
P. Devillier France
Sergio Parra
Citations per year, relative to Sergio Parra Sergio Parra (= 1×) peers P. Devillier

Countries citing papers authored by Sergio Parra

Since Specialization
Citations

This map shows the geographic impact of Sergio Parra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Parra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Parra more than expected).

Fields of papers citing papers by Sergio Parra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Parra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Parra. The network helps show where Sergio Parra may publish in the future.

Co-authorship network of co-authors of Sergio Parra

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Parra. A scholar is included among the top collaborators of Sergio Parra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Parra. Sergio Parra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Parra, Sergio, et al.. (2025). Evaluation of sevoflurane volatilization from gel and microsphere formulations and prediction of workplace exposure. Environmental Toxicology and Pharmacology. 114. 104651–104651.
3.
Sager, Jennifer E., Sergio Parra, Jennifer Moore, et al.. (2024). Pharmacokinetics of the Monoclonal Antibody, Sotrovimab, in Healthy Participants Following IM Administration at Different Injection Sites. Clinical Pharmacology & Therapeutics. 117(3). 759–767.
4.
Baker, Jillian G., Dianne M. Perez, Sergio Parra, et al.. (2024). Adrenoceptors in GtoPdb v.2024.2. IUPHAR/BPS Guide to Pharmacology CITE. 2024(2).
5.
Moore, Jennifer, et al.. (2023). 517. Safety and Tolerability of Intramuscular (IM) Sotrovimab 500 mg Administered at Different Injection Sites: Results from the Phase I COSMIC Study. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
6.
Moya, Jaynier, Sergio Parra, Erick Stanley Petersen Juárez, et al.. (2023). Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial. Open Forum Infectious Diseases. 10(7). ofad344–ofad344. 2 indexed citations
7.
Kim, Hosu, Nour A. Al‐Sawalha, Radhika Joshi, et al.. (2016). Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase–Knockout Mice. American Journal of Respiratory Cell and Molecular Biology. 55(2). 234–242. 18 indexed citations
8.
Sjögren, Benita, Sergio Parra, Kevin B. Atkins, Behirda Karaj, & Richard R. Neubig. (2016). Digoxin-Mediated Upregulation of RGS2 Protein Protects against Cardiac Injury. Journal of Pharmacology and Experimental Therapeutics. 357(2). 311–319. 24 indexed citations
9.
Parra, Sergio, Xinyan Huang, Raelene A. Charbeneau, et al.. (2014). Conditional disruption of interactions between Gαi2 and regulator of G protein signaling (RGS) proteins protects the heart from ischemic injury. BMC Pharmacology and Toxicology. 15(1). 29–29. 8 indexed citations
10.
Sjögren, Benita, et al.. (2012). Cardiotonic Steroids Stabilize Regulator of G Protein Signaling 2 Protein Levels. Molecular Pharmacology. 82(3). 500–509. 26 indexed citations
11.
Kaur, Kuljeet, Sergio Parra, Raelene A. Charbeneau, et al.. (2012). Gαi2 signaling: friend or foe in cardiac injury and heart failure?. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(5). 443–453. 11 indexed citations
12.
Parra, Sergio, et al.. (2012). Dehydroepiandrosterone effect on Plasmodium falciparum and its interaction with antimalarial drugs. Experimental Parasitology. 133(1). 114–120. 7 indexed citations
13.
Nguyễn, Long, Rui Lin, Sergio Parra, et al.. (2009). β 2 -Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proceedings of the National Academy of Sciences. 106(7). 2435–2440. 81 indexed citations
14.
Ríos, Juan Carlos, et al.. (2008). Role of four polymorphisms of the β-2 adrenergic receptor gen in patients with preterm delivery.. Colombia medica. 39(1). 7–15. 1 indexed citations
15.
Lin, Rui, Hui Peng, Long Nguyễn, et al.. (2007). Changes in β2-adrenoceptor and other signaling proteins produced by chronic administration of ‘β-blockers’ in a murine asthma model. Pulmonary Pharmacology & Therapeutics. 21(1). 115–124. 61 indexed citations
16.
Hanania, Nicola A., Michael Flashner, A. E. Franklin, et al.. (2007). The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study. Pulmonary Pharmacology & Therapeutics. 21(1). 134–141. 89 indexed citations
17.
Nguyễn, Long, Ozozoma Omoluabi, Sergio Parra, et al.. (2007). Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model. American Journal of Respiratory Cell and Molecular Biology. 38(3). 256–262. 109 indexed citations
18.
Bond, Richard A., Domenico Spina, Sergio Parra, & Clive Page. (2007). Getting to the heart of asthma: Can “β blockers” be useful to treat asthma?. Pharmacology & Therapeutics. 115(3). 360–374. 28 indexed citations
19.
Parra, Sergio & Richard A. Bond. (2007). Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant?. Current Opinion in Pharmacology. 7(2). 146–150. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. Devillier Breakdown of academic impact, for papers by F Perretti Breakdown of academic impact, for papers by Annet B. Zuidhof Breakdown of academic impact, for papers by K H Muntz Breakdown of academic impact, for papers by T J Torphy Breakdown of academic impact, for papers by Kihachi Ohshima Breakdown of academic impact, for papers by Adrian N. Payne Breakdown of academic impact, for papers by Blanca Bazán‐Perkins Breakdown of academic impact, for papers by Carl P. Nelson Breakdown of academic impact, for papers by Marilyn Grous
Rankless by CCL
2026